Jared Travers

Jared Travers

Auto-generated profile, based on publicly available information

Jared Travers

Division of Allergy and Immunology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2011 in Immunity
Verified
Journal Article
Closed access
GSGretta L. Stritesky
Gretta L. Stritesky
RMRajarajeswari Muthukrishnan
Rajarajeswari Muthukrishnan
SSSarita Sehra
Sarita Sehra
RGRitobrata Goswami
Ritobrata Goswami
DPDuy Pham
Duy Pham
MKMark H. Kaplan
Mark H. Kaplan

25 March 2015 in Mucosal Immunology
Verified
Journal Article
Open access
PDF file
JTJ Travers
J Travers
MRM E Rothenberg
M E Rothenberg
Eosinophils, multifunctional cells that contribute to both innate and adaptive immunity, are involved in the initiation, propagation, and resolution of immune responses, including tissue repair. They achieve this multifunctionality by expression of a diverse set of activation receptors, including those that directly recognize pathogens and opsonized targets, and by their ability to store and release preformed cytotoxic mediators that participate in host defense, to produce a variety of de novo pleotropic mediators and cytokines, and to interact directly and indirectly with diverse cell types, including adaptive and innate immunocytes and structural cells. Herein, we review the basic biology of eosinophils and then focus on new emerging concepts about their role in mucosal immune homeostasis, particularly maintenance of intestinal IgA. We review emerging data about their development and regulation and describe new concepts concerning mucosal eosinophilic diseases. We describe recently developed therapeutic strategies to modify eosinophil levels and function and provide collective insight about the beneficial and detrimental functions of these enigmatic cells.

7 April 2016 in JCI Insight
Verified
Journal Article
Open access
PDF file
BDBenjamin P. Davis
Benjamin P. Davis
ESEmily M. Stucke
Emily M. Stucke
MKM. Eyad Khorki
M. Eyad Khorki
VLVladislav A. Litosh
Vladislav A. Litosh
JRJeffrey K. Rymer
Jeffrey K. Rymer
MRMarc E. Rothenberg
Marc E. Rothenberg
We recently identified a genome-wide genetic association of eosinophilic esophagitis (EoE) at 2p23 spanning the calpain 14 ( CAPN14 ) gene, yet the causal mechanism has not been elucidated. We now show that recombinant CAPN14 cleaves a calpain-specific substrate and is inhibited by 4 classical calpain inhibitors: MDL-28170, acetyl-calpastatin, E-64, and PD151746. CAPN14 is specifically induced (>100-fold) in esophageal epithelium after IL-13 treatment. Epithelial cells overexpressing CAPN14 display impaired epithelial architecture, characterized by acantholysis, epidermal clefting, and epidermolysis. CAPN14 overexpression impairs epithelial barrier function, as demonstrated by decreased transepithelial resistance (2.1-fold) and increased FITC-dextran flux (2.6-fold). Epithelium with gene-silenced CAPN14 demonstrates increased dilated intercellular spaces (5.5-fold) and less organized basal cell layering (1.5-fold) following IL-13 treatment. Finally, CAPN14 overexpression results in loss of desmoglein 1 (DSG1) expression, whereas the IL-13–induced loss of DSG1 is normalized by CAPN14 gene silencing. Importantly, these findings were specific to CAPN14, as they were not observed with modulation of CAPN1 expression. These results, along with the potent induction of CAPN14 by IL-13 and genetic linkage of EoE to the CAPN14 gene locus, demonstrate a molecular and cellular pathway that contributes to T helper type 2 responses in mucosal epithelium.

14 August 2018 in Nature Communications
Verified
Journal Article
Open access
PDF file
JTJared Travers
Jared Travers
MRMark Rochman
Mark Rochman
CMCora E. Miracle
Cora E. Miracle
JHJeff E. Habel
Jeff E. Habel
MBMichael Brusilovsky
Michael Brusilovsky
MRMarc E. Rothenberg
Marc E. Rothenberg
IL-33 is an epithelium-derived, pro-inflammatory alarmin with enigmatic nuclear localization and chromatin binding. Here we report the functional properties of nuclear IL-33. Overexpression of IL-33 does not alter global gene expression in transduced epithelial cells. Fluorescence recovery after photobleaching data show that the intranuclear mobility of IL-33 is ~10-fold slower than IL-1α, whereas truncated IL-33 lacking chromatin-binding activity is more mobile. WT IL-33 is more resistant to necrosis-induced release than truncated IL-33 and has a relatively slow, linear release over time after membrane dissolution as compared to truncated IL-33 or IL-1α. Lastly, IL-33 and histones are released as a high-molecular weight complex and synergistically activate receptor-mediated signaling. We thus propose that chromatin binding is a post-translational mechanism that regulates the releasability and ST2-mediated bioactivity of IL-33 and provide a paradigm to further understand the enigmatic functions of nuclear cytokines.

1 September 2017 in Journal of Allergy and Clinical Immunology
Verified
Journal Article
Closed access
MRMark Rochman
Mark Rochman
JTJared Travers
Jared Travers
CMCora E. Miracle
Cora E. Miracle
MBMary C. Bedard
Mary C. Bedard
TWTing Wen
Ting Wen
MRMarc E. Rothenberg
Marc E. Rothenberg

1 May 2024 in Hepatology
Verified
Journal Article
Closed access
FRFernanda Raya-Tonetti
Fernanda Raya-Tonetti
AEAlvaro Eguileor
Alvaro Eguileor
MMMarko Mrdjen
Marko Mrdjen
VPVai Pathak
Vai Pathak
JTJared Travers
Jared Travers
CLCristina Llorente
Cristina Llorente
The growing recognition of the role of the gut microbiome’s impact on alcohol-associated diseases, especially in alcohol-associated liver disease, emphasizes the need to understand molecular mechanisms involved in governing organ-organ communication to identify novel avenues to combat alcohol-associated diseases. The gut-liver axis refers to the bidirectional communication and interaction between the gut and the liver. Intestinal microbiota plays a pivotal role in maintaining homeostasis within the gut-liver axis, and this axis plays a significant role in alcohol-associated liver disease. The intricate communication between intestine and liver involves communication between multiple cellular components in each organ that enable them to carry out their physiological functions. In this review, we focus on novel approaches to understanding how chronic alcohol exposure impacts the microbiome and individual cells within the liver and intestine, as well as the impact of ethanol on the molecular machinery required for intraorgan and interorgan communication.